We have purified and determined the complete primary structure of human stromelysin, a secreted metalloprotease with a wide range of substrate specificities. Human stromelysin is synthesized in a preproenzyme form with a calculated size of 53,977 Da and a 17-amino acid long signal peptide. Prostromelysin is secreted in two forms, with apparent molecular masses on NaDodSO4/PAGE of 60 and 57 kDa. The minor 60-kDa polypeptide is a glycosylated form of the major 57-kDa protein containing N-linked complex oligosaccharides. Zymogen activation by trypsin results in the removal of 84 amino acids from the amino terminus of the enzyme generating a 45-kDa active enzyme species. Human stromelysin is capable of degrading proteoglycan, fibronectin, lamiiin, and type IV collagen but not interstitial type I collagen. The enzyme is not capable of activating purified human fibroblast procollagenase. Analysis of its primary structure shows that stromelysin is in all likelihood the human analog of rat transin, which is an oncogene transformation-induced protease. The pattern of enzyme expression in normal and tumorigenic cells revealed that human skin fibroblasts in vitro secrete stromelysin constitutively (1-2 jug per 106 cells per 24 hr). Human fetal lung fibroblasts transformed with simian virus 40, human bronchial epithelial cells transformed with the ras oncogene, fibrosarcoma cells (HT-1080), and a melanoma cell strain (A 2058), do not express this protease nor can the enzyme be induced in these cells by treatment with phorbol 12-myristate 13-acetate. Our data indicate that the expression and the possible involvement of secreted metalloproteases in tumorigenesis result from a specific interaction between the transforming factor and the target cell, which may vary in different species.
minor 60-kDa polypeptide is a glycosylated form of the major 57-kDa protein containing N-linked complex oligosaccharides. Zymogen activation by trypsin results in the removal of 84 amino acids from the amino terminus of the enzyme generating a 45-kDa active enzyme species. Human stromelysin is capable of degrading proteoglycan, fibronectin, lamiiin, and type IV collagen but not interstitial type I collagen. The enzyme is not capable of activating purified human fibroblast procollagenase. Analysis of its primary structure shows that stromelysin is in all likelihood the human analog of rat transin, which is an oncogene transformation-induced protease. The pattern of enzyme expression in normal and tumorigenic cells revealed that human skin fibroblasts in vitro secrete stromelysin constitutively (1-2 jug per 106 cells per 24 hr). Human fetal lung fibroblasts transformed with simian virus 40, human bronchial epithelial cells transformed with the ras oncogene, fibrosarcoma cells (HT-1080) , and a melanoma cell strain (A 2058), do not express this protease nor can the enzyme be induced in these cells by treatment with phorbol 12-myristate 13-acetate. Our data indicate that the expression and the possible involvement of secreted metalloproteases in tumorigenesis result from a specific interaction between the transforming factor and the target cell, which may vary in different species.
The extracellular matrix (ECM) of multicellular organisms plays an active role in the formation and maintenance of tissues. The meshwork of ECM macromolecules is deposited by resident cells and provides a substrate for cell adhesion and migration, as well as a permeability barrier in cell-cell communication. A number of processes in normal tissue maintenance [e.g., wound healing (1, 2), bone resorption (3), and uterine involution (4) ] as well as certain pathologic processes [for example, rheumatoid arthritis (5, 6), epidermolysis bullosa (7, 8) , corneal (9, 10) and gingival disease (11) ] require connective tissue remodeling, involving a guided degradation of the preexisting ECM. Secreted proteases, required for initiation of degradation of the proteinaceous components of the ECM, also play an important part in processes requiring cell movement, such as tumor invasion and metastasis (12, 13) . These enzymes constitute a family of structurally related metalloendoproteases. Previously, we characterized the expression, properties, and primary structure of human fibroblast collagenase (14) (15) (16) , an enzyme responsible for the initiation of interstitial collagen degradation. In this report, we present the characterization of human fibroblast stromelysin, a proteoglycanase closely related to collagenase with a rather wide range of substrate specificities. The initial data on stromelysin expression in normal and tumor cell strains in vitro suggest that regulation of ECM metalloprotease expression is cell-type specific and may vary among species.
MATERIALS AND METHODS
Cell lines used in this report have been described (15) . In addition, human fetal lung fibroblast IMR-90 and IMR-90 transformed with simian virus 40 (SV40) (AG 2805) were from the Human Genetic Mutant Repository (Camden, NJ). Human fibrosarcoma cell line (HT-1080) was obtained from the American Type Culture Collection. Human keratinocytes, melanoma cell line A2058, and TBE-1 (17) were gifts from A. Pentland (Washington University), L. Liotta (National Institutes of Health), and G. Yoakum (National Institutes of Health), respectively. Cell culture and treatment with phorbol 12-myristate 13-acetate (PMA) and tunicamycin were described in a preceding publication (15) . Cells were labeled for 16 hr with [3H]leucine at 20 ,uCi/ml (154 Ci/mmol; 1 Ci =37 GBq) in serum-free medium without leucine or with 200 ,Ci of [3H]mannose per ml in low glucose medium. All methods used in this report, including DNA sequencing, oligonucleotide synthesis, primer extension, in vitro translation, RNA blot and immunoblot analysis, colony screening, proenzyme activation, and digestion with endoglycosidases F and H were performed as described in reports on human fibroblast collagenase without significant modifications (15, 16) . Amino-terminal protein sequences ofprostromelysin and the activated 45-kDa form of stromelysin were determined as described (16) , except NaDodSO4 gels were electroblotted on Polybrene-coated glass fiber filters in neutral pH buffer (18) , and bands were visualized under UV light. Monospecific antiserum was prepared by injecting rabbits at weekly intervals (three times) with a NaDodSO4 gel slice containing -25 ,ug of the 57-kDa protein species emulsified with an equal volume of Freund's adjuvant in water.
A simplified three-step procedure for the isolation of prostromelysin from human skin fibroblast (WU 80547) conditioned medium, yielding 50-100 ,ug of enzyme per liter was developed as outlined below. Collected serum-free medium was adjusted to blast procollagenase as described (15), The caseinolytic metalloprotease of 60 and 57 kDa was purified (Fig. 1, lane 5) using the three-step purification procedure (as described in Materials and Methods). The results presented in Fig. 2A (lane 3) show that a monospecific antiserum raised against the major 57-kDa polypeptide species also recognizes a minor 60-kDa protein secreted from biosynthetically labeled human skin fibroblasts. Therefore, we investigated whether the 60-kDa protein is a glycosylated version of the 57-kDa major form of the enzyme similar to that observed for fibroblast procollagenase (15) . [3H]Mannose was incorporated exclusively into the 60-kDa species ofthe enzyme ( Fig. 2A, lane 1) . Treatment of cultured fibroblasts with tunicamycin resulted in complete and selective inhibition of synthesis of the 60-kDa proenzyme (lane 5). The results of the experiment shown in Fig. 2B confirm that the 60-kDa proenzyme form contains N-linked complex oligosaccharides. The glycosylated 60-kDa polypeptide was sensitive to digestion with endoglycosidase F (24), while treatment with endoglycosidase H, an enzyme specific for high mannose type oligosaccharides (25), had no effect (Fig. 2B, lanes 2 and 4) . Fig. 3A (lane 2) shows an in vitro cell-free translation of mRNA from human skin fibroblast strain WUN 80547, with a single immunoprecipitable band of 59 kDa, apparently due to the presence of an uncleaved signal peptide.
The purified proenzyme was 95% inactive using [I4C]casein as substrate unless activated by limited proteolysis with trypsin or by treatment with the organomercurial paminophenylmercuric acetate as described for fibroblast procollagenase (26) . As shown in Fig. 1 (lanes 6-8) pepsin (22) . The pH optimum for this metalloprotease was 7.5-8.0, and the enzyme was inhibited by the metal chelators EDTA and 1,10-phenanthroline, by dithiothreitol, and by the 28-kDa tissue metalloprotease inhibitor (data not shown). Although the activated enzyme had negligible activity against collagen fibrils, it did exhibit some activity against [14C]gelatin (125 units/mg). This specific activity is at least 1/10th that reported for purified gelatinases (20, 27) . Taken together, these data on molecular mass, proenzyme activation, substrate specificity, and inhibition profile indicate that this metalloprotease is very similar, if not identical to stromelysin (proteoglycanase) isolated from rabbit synovial fibroblasts (23) and rabbit bone cultures (28) and the matrix metalloprotease 3, purified from human rheumatoid synovial cells (29) .
Complete Primary Structure of Human Stromelysin Suggests That this Protease Is an Analog of Rat Transin. A preparation of prostromelysin and the active 45-kDa enzyme species were separated by NaDodSO4/PAGE and subjected to amino acid sequence analysis as described in Materials and Methods. The NH2-terminal amino acid sequences of the 57-kDa proenzyme and the 45-kDa active enzyme forms were found to be Tyr-Pro-Leu-Asp-Ala-Ala-Arg-Gly-Glu-Asp-Thr and Thr-Phe-Pro-Gly-Ile-Pro, respectively. The sequence Thr-Phe-Pro-Gly-Ile-Pro was reverse-translated and a 17-base long oligonucleotide probe TGIAAAGGICITAATGG (SO10) containing 3 inosine residues was synthesized. A cDNA library constructed from WUN 80547 mRNA as reported (16) was screened with the SO10 oligomer. A number of clones were purified by colony hybridization and shown to be similar by restriction endonuclease mapping. The 5' end of the largest clone pSL45.5, which contained a 1675-base-pair (bp) insert, excluding the oligo(G) and poly(A) tails, was sequenced. A 20-base long oligomer, S012, was synthesized using a nucleotide sequence derived from the 5' end ofclone pSL45.5. The cDNA library was rescreened with the S012 oligomer and clone pSL51.4, representing the complete mRNA sequence coding for preprostromelysin, was purified. The clone pSL51.4 contains an insert of 1802 bp and hybridizes to an mRNA species of2.3 kilobases (kb) (Fig.  3B, lane 1) . The complete sequence of the pSL51.4 has been determined and confirmed on both strands (30) . The sequence is not presented in this report.* The insert consists of a 49-bp 5' untranslated leader, followed by an ATG methionine codon, and 1431 nucleotides coding for a 477-amino acid long preprostromelysin protein of a predicted size of 53,977 Da. The 3' untranslated region includes 321 (Fig. 4) shows that human stromelysin is more closely related to rat transin (75% homology) than to human collagenase (55% homology). In addition, human stromelysin contains both the three-and nine-amino acid insertions that are present in the rat gene and required for alignment with collagenae. All cysteines (at positions 11, 92, 290, and 477) in human stromelysin are conserved in transin. A putative glycosylation site, asparagine-120, is also conserved. All three metalloproteases contain a triplet of basic amino acids (positions 54-56) immediately preceding the site of trypsin cleavage during zymogen activation (33) function in the activation of these enzymes in vivo by other serine proteases such as plasmin and plasminogen activators (12, 34) . These observations, together with the fact that rat transin is a secreted protease (32), lead to the conclusion that stromelysin is in all likelihood a human analog of transin. The Expression of Stromelysin Is Cell Type Specific and Does Not Necessarily Correlate with Tumorigenic Transformation. The expression of the transin gene in fetal rat fibroblasts is induced upon transformation with polyomavirus, Rous sarcoma virus, and the activated oncogene Ha-ras (31) . In addition, Matrisian et al. (32) have recently shown that transin mRNA is present at significantly higher levels in chemically induced skin carcinomas than in normal skin or benign papillomas. The question arises, then, as to whether the expression of stromelysin is regulated by oncogene expression or treatment with PMA. We have addressed this question by measuring stromelysin and collagenase secretion by normal and transformed cell strains (Fig. 5) . Cultured human skin fibroblasts (Fig. 5, AdSk) secrete a significant amount of stromelysin constitutively and the level of expression can be increased further by treatment with PMA (Fig. 5,  AdSk+) . The constitutive expression of stromelysin, as well as its stimulation by PMA, in fetal skin fibroblasts, human colon, cornea, and gingiva parallels the expression of collagenase (15) . In contrast, human endothelial cells and the melanoma cell strain A2508 [ Fig. 5 HuE (-) and A2058 (-)] secrete significant amounts of collagenase but not stromelysin (see Fig. 3B, lane 3) ; PMA treatment of these cells does not stimulate stromelysin expression (Fig. 5 HuE+, A2058+). Human keratinocytes cultured in vitro express a low amount of stromelysin, which was not stimulated by treatment with PMA (Fig. 5, Ker) . The fibrosarcoma cell strain HT-1080 and SV40-transformed human fetal lung fibroblasts secrete low levels of collagenase and no detectable stromelysin [HT-1080(-), SV40(-), and Fig. 3B, lane 2] . Treatment of these cells with PMA causes an increased expression of collagenase but had no effect on stromelysin expression. The parental fetal lung fibroblast cells IMR-90 express low levels of collagenase and stromelysin that can be stimulated by PMA treatment but the effect of PMA on stromelysin expression by these cells is very limited. Of special interest is the fact that human bronchial epithelial cells transformed with activated Ha-ras oncogene (17) been observed in rabbit synovial cells, alveolar macrophages, and brain endothelial cells (35) . Our observations suggest that the regulation of ECM protease expression, and consequently their individual roles in tissue remodeling or in tumor invasion (metastasis), is cell-type specific and possibly varies among species.
DISCUSSION
Human skin fibroblasts in tissue culture constitutively secrete a number of metalloendoproteases that initiate the degradation of extracellular matrix components. These enzymes comprise a group of structurally related proteins with distinct, but in the case of stromelysin rather broad, substrate specificity. In addition, collagenase and stromelysin undergo partial posttranslational modification, and proenzyme activation leads to the appearance of active intermediates of different molecular size. These facts point out the importance of a systematic characterization of each member of the group by protein sequence analysis, complete structural analysis on a cDNA level, and the characterization of substrate specificity of the purified enzymes. This point is well illustrated by the recent report comparing the structure of the secreted rat protease transin and the putative protease transin 2 (36) . The structural similarity between these two proteins is so extensive that identification on the level of cDNA hybridization or reaction with polyclonal antibody alone is likely to produce confusing results.
Stromelysin purified from human skin fibroblast conditioned medium is 95% inactive against a casein substrate. The NH2-terminal sequence of the proenzyme form of stromelysin is Tyr-Pro-Leu-Asp-Ala-Ala-Arg-Gly-Glu-Asp-Thr. Lim Recently, there have been several reports of metalloproteases distinct from interstitial collagenase (38) and gelatinase (39) , which degrade proteoglycans, gelatin, and other connective tissue components. Galloway et al. (28) purified a metalloprotease in an active form of 24 kDa, which degrades proteoglycans from rabbit bone culture medium. Antibodies to rabbit bone proteoglycanase immunoprecipitated a higher molecular mass proenzyme species of 51 kDa from PMA-treated rabbit synovial fibroblasts, which was named stromelysin or proteoglycanase. The substrate specificities, inhibition profiles, and pH optima of both the low molecular mass (28 kDa) and the high molecular mass (45 kDa) active matrix metalloprotease-3 forms (29) , isolated from human rheumatoid synovial cells, appear to be identical to rabbit and human fibroblast stromelysin. Although the relationship of human stromelysin and metalloprotease-3 to a latent neutral proteoglycanase (68 kDa) purified from tissue extracts of human cartilage (40) remains to be elucidated, they appear to be distinct from a metalloprotease of 70 kDa isolated from tumor cells (41) and adherent macrophages (42) , which degrades types IV but not type I collagen. The sequence of stromelysin from human skin fibroblasts presented here is in agreement with that of a putative stromelysin cDNA clone isolated from a human gingival fibroblast cDNA Proc. Natl. Acad. Sci. USA 84 (1987) 6729 library by cross-hybridization to a partial rabbit stromelysin cDNA clone (43) .
Our data indicate that a single mRNA species codes for both secreted proenzyme forms of human fibroblast stromelysin of 60 and 57 kDa. As with procollagenase (15), the minor 60-kDa polypeptide is the result of partial N-linked glycosylation, apparently through the addition of complex oligosaccharide(s) to the unmodified proenzyme species at one or both of the possible N-glycosylation recognition sites (Asn120,Asn31) found in the primary structure of the enzyme.
Partial N-linked glycosylation appears to be a common feature in the biosynthesis of both collagenase and stromelysin by cultured cells. Although the physiological function of glycosylation is not known, it may be an important factor in targeting these metalloproteases to different compartments of the extracellular matrix.
In a previous report we measured collagenase synthesis in a variety of normal cell strains (15) and compared this to enzyme production by two leukocyte tumor cell strains (44, 45) . The results indicated that the expression of collagenase is tissue specific and regulated developmentally. Generally, a similar notion concerning the expression of human stromelysin can be forwarded based on the observations presented here. It is clear from our data that the specific pattern of human stromelysin expression is distinct from that of collagenase. In the cell strains of fibroblast origin, collagenase and stromelysin are secreted at similar rates, and both enzymes can be stimulated with PMA treatment. Treatment with PMA, however, failed to induce or stimulate stromelysin synthesis in normal human endothelial cells, keratinocytes, and several tumor cell lines, including melanoma, fibrosarcoma, SV40-transformed fetal lung fibroblasts, and Haras-transformed bronchial epithelial cells. These observations are of particular interest in view of the fact that the sequence homology between human stromelysin and rat transin and transin 2 genes strongly suggests that stromelysin is a human analog of transin. In addition, expression of the transin gene is readily stimulated in fetal rat fibroblasts by a variety of transforming agents with the exception of SV40, while more selective induction is observed for the transin 2 gene (36) . The expression of the transin gene is significantly increased in experimentally induced rat carcinomas compared to normal skin or benign papillomas (32) . This is consistent with the notion that increased expression of secreted proteases plays an important role in tumor invasion (12, 13) . Our observations on the expression of collagenase and stromelysin indicate that the induction of metalloprotease synthesis is the result of interaction between a specific cell type and the transforming agent, which leads us to conclude that the specific role of each ECM protease in the progression of a variety of tumors has to be addressed individually.
